AccueilBBN • SWX
add
Bellevue Group AG
Dernière clôture
14,75 CHF
Variation sur la journée
14,50 CHF - 14,80 CHF
Plage sur l'année
11,05 CHF - 24,30 CHF
Capitalisation boursière
195,19 M CHF
Volume moyen
9,95 k
Ratio cours/bénéfices
13,08
Rendement (dividendes)
7,93 %
Place boursière principale
SWX
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(CHF) | juin 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 18,41 M | -11,31 % |
Charges d'exploitation | 13,73 M | -10,56 % |
Résultat net | 3,72 M | -7,22 % |
Marge bénéficiaire nette | 20,18 | 4,61 % |
Bénéfice par action | — | — |
EBITDA | — | — |
Taux d'imposition effectif | 17,26 % | — |
Bilan
Total des actifs
Total du passif
(CHF) | juin 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 30,49 M | 100,63 % |
Total des actifs | 138,75 M | -4,69 % |
Total du passif | 22,05 M | -24,81 % |
Total des capitaux propres | 116,70 M | — |
Actions en circulation | 13,20 M | — |
Ratio cours/valeur comptable | 1,67 | — |
Rentabilité des actifs | 10,71 % | — |
Retour sur capitaux | — | — |
Flux de trésorerie
Variation nette en trésorerie
(CHF) | juin 2024info | Variation Y/Y |
---|---|---|
Résultat net | 3,72 M | -7,22 % |
Trésorerie (opérations) | 3,65 M | 137,31 % |
Trésorerie (invest.) | — | — |
Trésorerie (financement) | -8,10 M | 45,85 % |
Variation nette en trésorerie | -4,17 M | 83,13 % |
Flux de trésorerie dispo. | — | — |
À propos
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Date de fondation
1993
Site Web
Employés
88